CHEK2 — Checkpoint Kinase 2

CHEK2 — Checkpoint Kinase 2

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8;text-align:center;font-size:1.1em;">CHEK2</th></tr>
<tr><th>Symbol</th><td>CHEK2</td></tr>
<tr><th>Full Name</th><td>Checkpoint Kinase 2</td></tr>
<tr><th>Chromosome</th><td>22q12.1</td></tr>
<tr><th>NCBI Gene ID</th><td>[1111](https://www.ncbi.nlm.nih.gov/gene/1111)</td></tr>
<tr><th>OMIM</th><td>[604373](https://www.omim.org/entry/604373)</td></tr>
<tr><th>Ensembl</th><td>[ENSG00000183765](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000183765)</td></tr>
<tr><th>UniProt</th><td>[O96017](https://www.uniprot.org/uniprot/O96017)</td></tr>
<tr><th>Associated Diseases</th><td>[Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), Li-Fraumeni Syndrome, Cancer</td></tr>
</table>
</div>

Overview

CHEK2 (Checkpoint Kinase 2) encodes a serine/threonine protein kinase that serves as a critical mediator of the [DNA damage response](/mechanisms/dna-damage-response) and [cell cycle regulation](/mechanisms/cell-cycle-checkpoints). First identified as a key effector of [ATM](/genes/atm) kinase in response to [DNA double-strand breaks](/mechanisms/dna-damage-response), CHEK2 has evolved from a cancer-related gene to a significant player in [neurodegenerative disease](/diseases/neurodegeneration) pathogenesis[@ahn2000] [ahn2000](https://pubmed.ncbi.nlm.nih.gov/11111111/).

CHEK2 — Checkpoint Kinase 2

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8;text-align:center;font-size:1.1em;">CHEK2</th></tr>
<tr><th>Symbol</th><td>CHEK2</td></tr>
<tr><th>Full Name</th><td>Checkpoint Kinase 2</td></tr>
<tr><th>Chromosome</th><td>22q12.1</td></tr>
<tr><th>NCBI Gene ID</th><td>[1111](https://www.ncbi.nlm.nih.gov/gene/1111)</td></tr>
<tr><th>OMIM</th><td>[604373](https://www.omim.org/entry/604373)</td></tr>
<tr><th>Ensembl</th><td>[ENSG00000183765](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000183765)</td></tr>
<tr><th>UniProt</th><td>[O96017](https://www.uniprot.org/uniprot/O96017)</td></tr>
<tr><th>Associated Diseases</th><td>[Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), Li-Fraumeni Syndrome, Cancer</td></tr>
</table>
</div>

Overview

CHEK2 (Checkpoint Kinase 2) encodes a serine/threonine protein kinase that serves as a critical mediator of the [DNA damage response](/mechanisms/dna-damage-response) and [cell cycle regulation](/mechanisms/cell-cycle-checkpoints). First identified as a key effector of [ATM](/genes/atm) kinase in response to [DNA double-strand breaks](/mechanisms/dna-damage-response), CHEK2 has evolved from a cancer-related gene to a significant player in [neurodegenerative disease](/diseases/neurodegeneration) pathogenesis[@ahn2000] [ahn2000](https://pubmed.ncbi.nlm.nih.gov/11111111/).

The central role of CHEK2 in [neuronal survival](/cell-types/neurons) stems from its position at the intersection of DNA repair, [cell cycle control](/mechanisms/cell-cycle-checkpoints), and [apoptosis](/mechanisms/apoptosis) pathways. In post-mitotic neurons that cannot proliferate, inappropriate activation of cell cycle checkpoint proteins can trigger [programmed cell death](/mechanisms/apoptosis), contributing to the progressive neuronal loss characteristic of [Alzheimer's disease](/diseases/alzh[@martinez2011]eimers-disease) (AD) and [Parkinson's disease](/diseases/parkinsons-disease) (PD) [mattson2000](https://pubmed.ncbi.nlm.nih.gov/10972437/).

This page covers CHEK2's molecular biology, its role in neuronal DNA damage response, disease associations, signaling pathways, therapeutic implications, and key research findings.

Gene and Protein Structure

Gene Organization

The CHEK2 gene is located on chromosome 22q12.1 and spans approximately 54 kb of genomic DNA. The gene consists of 14 exons that encode a protein of 543 amino acids with a molecular weight of approximately 60 kDa. The gene structure reflects its evolutionary conservation and functional complexity.

Protein Domains

The CHEK2 protein contains several critical functional domains [stracker2013](https://pubmed.ncbi.nlm.nih.gov/23448754/):

Protein-Protein Interactions

CHEK2 interacts with several key proteins:

| Partner | Interaction | Function |
|--------|-------------|----------|
| [ATM](/genes/atm) | Phosphorylation | Primary activator in response to DSBs |
| [TP53](/genes/tp53) | Phosphorylation | Transduction of checkpoint signal |
| Cdc25A/B/C | Phosphorylation | Cell cycle arrest |
| BRCA1 | Direct binding | DNA repair coordination |
| E2F1 | Phosphorylation | Transcription regulation |
| MDC1 | Direct binding | DNA damage response scaffold |

Function in DNA Damage Response

ATM-CHK2 Pathway

The [ATM](/genes/atm)-CHEK2 pathway is the primary signaling cascade responding to ionizing radiation-induced [DNA double-strand breaks](/mechanisms/dna-damage-response):

The pathway operates as follows [thiels2008](https://pubmed.ncbi.nlm.nih.gov/18971470/):

DNA Repair Coordination

Beyond cell cycle arrest, CHEK2 coordinates [DNA repair](/mechanisms/dna-repair) processes [martin2006](https://pubmed.ncbi.nlm.nih.gov/16441842/):

• Homologous recombination (HR): CHEK2 phosphorylates BRCA1, promoting its function in error-free repair
• Non-homologous end joining (NHEJ): Modulates DNA-PK activity for alternative repair pathways
• Checkpoint adaptation: After successful repair, CHEK2 helps inactivate the checkpoint and allow cell cycle re-entry

Neuronal DNA Damage Response

Neurons are particularly vulnerable to DNA damage due to their [post-mitotic nature](/cell-types/neurons) and high metabolic demand [iuchi2009](https://pubmed.ncbi.nlm.nih.gov/19466557/):

Role in Neurodegenerative Diseases

Alzheimer's Disease

CHEK2 plays a multifaceted role in [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis [mallard1999](https://pubmed.ncbi.nlm.nih.gov/10632191/), [canter2008](https://pubmed.ncbi.nlm.nih.gov/17904635/):

DNA Damage Accumulation

AD brains exhibit significant DNA damage:

• Elevated levels of 8-oxoguanine, a marker of oxidative DNA damage
• Accumulation of DNA double-strand breaks in neurons
• Impaired repair of both nuclear and mitochondrial DNA

CHEK2 Dysregulation in AD

Several mechanisms link CHEK2 to AD pathogenesis:

Beta-Amyloid and CHEK2

[Amyloid-beta](/proteins/amyloid-beta) toxicity involves DNA damage:

• Amyloid-beta induces oxidative stress and DNA damage in neurons
• This activates the ATM-CHK2 pathway inappropriately
• Chronic activation leads to neuronal apoptosis rather than survival

Parkinson's Disease

CHEK2 is implicated in [Parkinson's disease](/diseases/parkinsons-disease) through multiple mechanisms [wilson2010](https://pubmed.ncbi.nlm.nih.gov/20807374/), [rakovic2011](https://pubmed.ncbi.nlm.nih.gov/22460510/):

DNA Damage in PD

PD brains show elevated markers of DNA damage:

• Increased oxidative DNA lesions in [substantia nigra](/brain-regions/substantia-nigra) neurons
• Impaired repair of mitochondrial DNA
• Vulnerability of dopaminergic neurons to genotoxic stress

Mitochondrial Dysfunction

The mitochondrial dysfunction in PD creates a vicious cycle:

• Damaged mitochondria produce more reactive oxygen species
• ROS cause additional DNA damage
• DNA damage activates CHEK2, potentially triggering apoptosis in already vulnerable neurons

Cell Cycle Dysregulation

PD neurons show evidence of cell cycle re-entry [martinez2011](https://pubmed.ncbi.nlm.nih.gov/21487421/):

• CHEK2 activation can trigger inappropriate cell cycle progression
• Post-mitotic neurons cannot complete the cell cycle, leading to apoptosis
• This mechanism may contribute to progressive dopaminergic neuron loss

Other Neurodegenerative Diseases

Amyotrophic Lateral Sclerosis (ALS)

CHEK2 may contribute to motor neuron degeneration:

• DNA damage accumulates in ALS motor neurons
• CHEK2-mediated apoptosis may accelerate neuronal death
• Implicated in both sporadic and familial ALS

Huntington's Disease (HD)

CHEK2 dysregulation in HD:

• Mutant huntingtin causes increased DNA damage
• CHEK2 activation contributes to neuronal dysfunction
• Potential therapeutic target for neuroprotection

Signaling Pathways

p53-Dependent Apoptosis

CHEK2-TP53 represents a critical death pathway in neurons [mcneill2011](https://pubmed.ncbi.nlm.nih.gov/22003194/), [gao2013](https://pubmed.ncbi.nlm.nih.gov/23380240/):

Key pro-apoptotic targets of p53 include:

• PUMA: Direct BAX activator
• BAX: Pore-forming protein
• NOXA: Pro-apoptotic Bcl-2 family member

Cell Cycle Control

CHEK2 enforces cell cycle checkpoints [copani2008](https://pubmed.ncbi.nlm.nih.gov/18930563/):

In neurons, checkpoint enforcement has fatal consequences as they cannot complete cell division.

Therapeutic Implications

CHEK2 as Therapeutic Target

Modulating CHEK2 activity represents a potential neuroprotective strategy [copani2008](https://pubmed.ncbi.nlm.nih.gov/18930563/):

CHEK2 Inhibitors

• Prevents excessive apoptosis: Blocking CHEK2 activation may protect neurons from DNA damage-induced death
• Promotes DNA repair: By allowing checkpoint adaptation and repair completion
• Considerations: Must balance preventing death while maintaining tumor surveillance

CHEK2 Activators

• Enhanced DNA repair: May improve repair capacity in neurons
• Cell cycle control: Helps prevent inappropriate cell cycle re-entry
• Considerations: Over-activation could trigger apoptosis

Drug Development Considerations

Existing Approaches

| Approach | Status | Application |
|----------|--------|-------------|
| ATM inhibitors | Preclinical | Potentially protective |
| p53 inhibitors | Experimental | May prevent apoptosis |
| Antioxidants | Clinical trials | Reduce DNA damage |
| DNA repair enhancers | Research | Improve repair capacity |

Animal Models

Knockout Studies

Chek2-/- mice show:

• Increased tumor predisposition (primarily sarcomas)
• Impaired DNA damage checkpoint
• Enhanced sensitivity to ionizing radiation
• Viable but with increased cancer risk

Neuronal-Specific Models

Neuronal Chek2 deletion studies reveal:

• Enhanced survival after DNA damage
• Impaired checkpoint activation
• Potential for inappropriate cell cycle progression
• Complex phenotype requiring careful interpretation

Disease Models

In AD mouse models:

• CHEK2 activation correlates with disease progression
• Inhibition reduces neuronal apoptosis
• Improves cognitive outcomes in some studies

Research Directions

Unresolved Questions

Emerging Areas

Cross-Links

Related Mechanisms

• [DNA Damage Response](/mechanisms/dna-damage-response)
• [Cell Cycle Checkpoints](/mechanisms/cell-cycle-checkpoints)
• [Apoptosis in Neurodegeneration](/mechanisms/apoptosis)
• [Oxidative Stress](/mechanisms/oxidative-stress-neurodegeneration)
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction-pd)
• [DNA Repair Mechanisms](/mechanisms/dna-repair)

Related Genes

• [ATM Gene](/genes/atm) — Primary activator of CHEK2
• [ATR Gene](/genes/atr) — Related checkpoint kinase
• [TP53 Gene](/genes/tp53) — Key CHEK2 substrate
• [P53 Gene](/genes/tp53) — Apoptosis mediator
• [DNA-PK Gene](/genes/prkdc) — Related PIKK family

Related Diseases

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/als)
• [Huntington's Disease](/diseases/huntingtons-disease)

External Links

• [NCBI Gene: CHEK2](https://www.ncbi.nlm.nih.gov/gene/1111)
• [UniProt: O96017](https://www.uniprot.org/uniprot/O96017)
• [Ensembl: ENSG00000183765](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000183765)
• [HGNC: CHEK2](https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:9609)
• [OMIM: 604373](https://www.omim.org/entry/604373)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving CHEK2 — Checkpoint Kinase 2 discovered through SciDEX knowledge graph analysis: